His lab is working on refining the alanine-scanning assay to a few important residues that could precisely distinguish among fibrils from neurodegenerative tauopathies. He envisions employing this streamlined assay for postmortem neuropathological analysis, And perhaps for blood screening of tauopathies.Within this assay, scientists add extracts fr